Sodium–glucose co‐transporter‐2 inhibitors: an emerging new class of oral antidiabetic drug
Authors:
- 29 December 2008
- journal article
- review article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 11 (2) , 79-88
Abstract
The sodium–glucose co‐transporter‐2 (SGLT2) is a low‐affinity transport system that is specifically expressed in the kidney and plays an important role in renal glucose reabsorption in the proximal tubule. Competitive inhibition of SGLT2 therefore represents an innovative therapeutic strategy for the treatment of hyperglycaemia and/or obesity in patients with type 1 or type 2 diabetes by enhancing glucose and energy loss through the urine. The observation that individuals with familial renal glycosuria maintain normal long‐term kidney function provides some reassurance that this mode of action will not adversely affect renal function. Intense research in this therapeutic area has led to the discovery of novel SGLT2 inhibitors, each with different chemical, pharmacodynamic and pharmacokinetic profiles. This review outlines the biology, expression and pleotropic activity of the SGLT system and the pharmacological profile of SGLT2 inhibitors and provides a summary of preclinical and limited clinical data available to characterize the efficacy, safety and potential clinical utility of SGLT2 inhibitors in the management of diabetes.Keywords
This publication has 42 references indexed in Scilit:
- Why Diabetes Incidence Increases—A Unifying TheoryAnnals of the New York Academy of Sciences, 2006
- Long-term treatment with the Na+-glucose cotransporter inhibitor T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki RatsLife Sciences, 2005
- SGLT as a therapeutic targetDrugs of the Future, 2004
- Diabetes Increases Facilitative Glucose Uptake and GLUT2 Expression at the Rat Proximal Tubule Brush Border MembraneThe Journal of Physiology, 2003
- DIFFERENCE IN THE EFFECT OF PHLORIDZIN ON ALVEOLAR FLUID ABSORPTION IN ANESTHETIZED RATS AND IN EX VIVO RAT LUNGSExperimental Lung Research, 1999
- Phlorizin, a Competitive Inhibitor of Glucose Transport, Facilitates Memory Storage in MiceNeurobiology of Learning and Memory, 1999
- Insulin-independent acute restoration of euglycemia normalizes the impaired glucose clearance during exercise in diabetic dogsDiabetes, 1997
- Biophysical Characteristics of the Pig Kidney Na+/Glucose Cotransporter SGLT2 Reveal a Common Mechanism for SGLT1 and SGLT2Journal of Biological Chemistry, 1996
- Phlorizin as a competitive inhibitor of the active transport of sugars by hamster small intestine, in vitroBiochimica et Biophysica Acta, 1962
- THE ACTION OF PHLORIZIN ON THE EXCRETION OF GLUCOSE, XYLOSE, SUCROSE, CREATININE AND UREA BY MANJournal of Clinical Investigation, 1933